Surgalign Holdings logo
Surgalign Holdings SRGA

Quarterly report 2023-Q1
added 05-11-2023

report update icon

Surgalign Holdings Income Statement 2011-2026 | SRGA

Annual Income Statement Surgalign Holdings

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

11.4 M 84.6 M 127 M 305 M 274 M 266 M 183 M 185 M 253 M 177 M 251 M 220 M

Shares

6.56 M 4.09 M 75.8 M 72.8 M 63.5 M 59.7 M 58.2 M 57.6 M 56.7 M 56.3 M 55.9 M 55.2 M

Historical Prices

1.74 20.7 50.4 125 132 135 97.5 96.3 134 93 148 104

Net Income

-54.6 M -84.7 M -33.8 M -212 M -1.25 M 6.27 M -14.4 M 14.9 M 2.7 M -17.8 M 8.4 M 8.38 M

Revenue

82 M 90.5 M 102 M 308 M 281 M 280 M 273 M 282 M 263 M 198 M 178 M 169 M

Cost of Revenue

41.7 M 29.8 M 44 M 32.8 M 33.6 M 36.4 M 143 M - - - - -

Gross Profit

40.3 M 60.7 M 57.7 M 171 M 140 M 143 M 132 M 150 M 134 M 80.1 M 85.2 M 77.2 M

Operating Income

-78.5 M -137 M -198 M -243 M -64.8 M -62.7 M -15.3 M - - - - -

Interest Expense

1.01 M 202 K 61 K 12.6 M 2.77 M 3.18 M 1.66 M - - - - -

EBITDA

-76.3 M -135 M -72 M 19.3 M 21.1 M 28.3 M 12.8 M 43.8 M 26 M -4.57 M 22.6 M 19.8 M

Operating Expenses

120 M 202 M 136 M 175 M 134 M 128 M 136 M 123 M 123 M 96.9 M 70.6 M 65.4 M

General and Administrative Expenses

95.9 M 104 M 124 M 158 M - - - - 4.8 M - 20 K -

All numbers in USD currency

Quarterly Income Statement Surgalign Holdings

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

8.07 M 7.86 M 6.74 M 6.64 M 5.73 M 4.89 M 4.61 M 3.81 M 98.1 M 81.7 M 73.2 M 72.6 M 72.9 M 75.2 M 72.5 M 75.1 M 65.7 M 63.5 M 63.5 M 63.4 M 63.2 M 62.7 M 60.5 M 59.4 M 58.5 M - 57.4 M 58 M 58 M - - - - - - - - - - - - - - - - - - - -

Net Income

4.14 M - -9.83 M -5.69 M 27 K - -7.91 M -16.2 M -15.2 M -100 M 123 M -38.6 M -17.9 M -197 M -5.14 M 188 K -9.35 M 799 K 3 M -5.8 M -1.12 M -7.23 M 17.7 M -1.66 M -1.88 M - -3.5 M -1.68 M 2.14 M - - - - - - - - - - - - - - - - - - - -

Revenue

16.7 M - 20.2 M 20.6 M 20.6 M - 20.5 M 24.8 M 23.3 M 26.2 M 27.9 M 20.5 M 27.1 M 31.6 M 28.7 M 32.7 M 24.4 M 23.1 M 24.1 M 22.4 M 22.5 M 71.1 M 67.2 M 71.6 M 70.4 M - 66.5 M 69.9 M 67.5 M - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

6.07 M - 5.49 M 6.41 M 6.41 M - 6.81 M 7.23 M 6.24 M - 11.9 M 9.47 M 9.22 M - 7.61 M 35.4 M 32.1 M - 32.2 M 40.5 M 35.6 M - 33.4 M 34.9 M 34.2 M - 32.4 M 35 M 31.8 M - - - - - - - - - - - - - - - - - - - -

Gross Profit

10.7 M - 14.7 M 14.2 M 14.2 M - 13.7 M 17.6 M 17.1 M 12.8 M 16 M 11.1 M 17.9 M 23.5 M 21.1 M 23.1 M 16.9 M 17.2 M 17.9 M 8.99 M 14.4 M 36.4 M 33.8 M 36.7 M 36.2 M - 34.1 M 34.9 M 35.7 M - - - - - - - - - - - - - - - - - - - -

Operating Income

-1.14 M - -8 M -13.4 M -8.92 M - -16.9 M -13.3 M -14.4 M - -26.6 M -25.1 M -27.9 M - -20.5 M 785 K -7.54 M - 4.91 M -7.46 M -167 K - 34.6 M 386 K -1.97 M - -3.57 M -1.73 M 3.69 M - - - - - - - - - - - - - - - - - - - -

Interest Expense

252 K - 252 K 252 K 252 K - 117 K - - - 21 K 5.97 M 3.56 M - 3.72 M 3.64 M 1.6 M - 611 K 777 K 835 K - 741 K 915 K 819 K - 308 K 392 K 361 K - - - - - - - - - - - - - - - - - - - -

EBITDA

-644 K - -6.26 M -12.2 M -8.36 M - -15.1 M -12.1 M -13.9 M - -20.6 M -20.4 M -25.6 M - -4.17 M 11.1 M -3.14 M - 15.7 M -396 K 3.42 M - 34.6 M 386 K 1.6 M - -3.57 M -1.73 M 8 M - - - - - - - - - - - - - - - - - - - -

Operating Expenses

24.4 M - 23.6 M 27.6 M 23.1 M - 34.6 M 30.9 M 31.5 M - 42.7 M 36.2 M 45.8 M - 41.6 M 45.3 M 45.4 M - 33.3 M 37.4 M 33.7 M - -780 K 36.3 M 38.2 M - 37.6 M 36.7 M 32 M - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

21.1 M - 23.9 M 24.3 M 25.3 M - 27.6 M 25.5 M 26.2 M - 27.7 M 32.1 M 37.2 M - 34.2 M 41.1 M 32.1 M - 29.7 M 29.3 M 28.4 M - 1.82 M 29.6 M 29.7 M - 28.8 M 28.4 M 27.9 M - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

The income statement is one of the three key financial reports of a company Surgalign Holdings (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 11.44 2.14 % $ 324 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 8.24 -0.06 % $ 1.24 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 4.33 1.88 % $ 162 M franceFrance
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 73.6 -0.15 % $ 4.01 B britainBritain
LENSAR LENSAR
LNSR
$ 6.0 2.04 % $ 71.7 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.32 0.47 % $ 51.2 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.44 -5.81 % $ 27.4 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 18.45 -0.24 % $ 433 M usaUSA
Delcath Systems Delcath Systems
DCTH
$ 11.44 1.87 % $ 410 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Profound Medical Corp. Profound Medical Corp.
PROF
$ 6.9 -0.29 % $ 209 M canadaCanada
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.01 1.0 % $ 17.1 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
MiMedx Group MiMedx Group
MDXG
$ 3.6 -5.15 % $ 532 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.55 0.65 % $ 63.1 M usaUSA
Electromed Electromed
ELMD
$ 38.75 2.49 % $ 328 M usaUSA
Myomo Myomo
MYO
$ 0.92 0.05 % $ 38.5 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.45 1.14 % $ 1.1 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 2.17 -1.58 % $ 6.02 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 10.15 -16.46 % $ 402 M curacaoCuracao
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Globus Medical Globus Medical
GMED
$ 84.32 0.37 % $ 11.4 B usaUSA
Insulet Corporation Insulet Corporation
PODD
$ 155.87 -0.46 % $ 11 B usaUSA
TransMedics Group TransMedics Group
TMDX
$ 68.0 - $ 2.31 B usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 36.74 -0.77 % $ 1.14 B usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 43.99 -0.36 % $ 1.29 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 90.09 -1.47 % $ 3.13 B usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 82.89 -0.12 % $ 48.5 B usaUSA